Member Exclusive NEWS ROUND-UP

Cell therapy weekly: immunotherapy effectively treats melanoma caused by CDKN2A mutation

This week in cell therapy: The global CAR T-cell therapy market has been forecasted to grow 63.15%, a new immunotherapy demonstrates effective treatment of a heredity melanoma and a clinical trial of stem cell therapy for eye injuries receives US$5.25 million grant.

Please sign in or register for FREE

No comments yet.